Table 4.
The susceptible pattern of gram-negative bacteria from diabetic foot patients.
| E. coli | Serratia | Klebsiella | Enterobacter | Proteusbacillus | Pseudomonas | baumannii | Morganella | |
|---|---|---|---|---|---|---|---|---|
| Macrodantin (%) | 79.3 | 10 | 35.1 | 55.6 | — | 2.6 | 14.3 | 0 |
| Ampicillin (%) | 21.9 | — | 5.4 | 0 | 55.6 | 0 | 0 | 0 |
| Ampicillin/sulbactam (%) | 25.8 | — | 48.6 | 0 | 73.7 | 5.9 | 50 | 0 |
| Piperacillin-tazobactam (%) | 87.9 | 100 | 94.6 | 84.2 | 100 | 74.4 | 80 | 96 |
| Sulfamethoxazole (%) | 31.3 | 94.7 | 67.6 | 61.9 | 52.6 | 5.3 | 64.3 | 40 |
| Cefazolin (%) | 22.2 | 5.3 | 27 | 18.8 | — | 0 | 0 | 3.8 |
| Cefoxitin (%) | — | — | — | — | 100 | — | — | — |
| Ceftriaxone (%) | 32.3 | 100 | 70.3 | 71.4 | — | 0 | 0 | 76.9 |
| Ceftazidime (%) | 62.5 | 100 | 89.2 | 81 | 100 | 87.2 | 66.7 | 88.5 |
| Cefotetan (%) | 90 | — | 94.6 | 9.1 | — | 0 | 0 | 100 |
| Cefepime (%) | 66.7 | 94.7 | 94.6 | 90.5 | 73.7 | 89.7 | 71.4 | 90.5 |
| Levofloxacin (%) | 39.4 | 94.7 | 83.8 | 75 | 73.7 | 89.5 | 73.3 | 92.3 |
| Ciprofloxacin (%) | 30.3 | 94.7 | 81.1 | 70 | 57.9 | 87.2 | 73.3 | 65.4 |
| Amikacin (%) | 46.9 | 78.9 | 75.7 | 76.2 | 63.2 | 87.2 | 93.3 | 53.8 |
| Tobramycin (%) | 97 | 100 | 94.6 | 93.3 | 88.9 | 89.5 | — | 88.5 |
| Gentamicin (%) | 46.9 | 94.7 | 78.4 | 95.2 | 68.4 | 84.6 | 93.3 | 53.8 |
| Meropenem (%) | — | — | — | — | 100 | 94.3 | — | 100 |
| Imipenem (%) | 93.5 | 89.5 | 100 | 100 | 68.4 | 82.1 | 73.3 | — |
| Ertapenem (%) | 96.4 | 100 | 100 | 94.7 | 100 | — | — | 100 |
| Aztreonam (%) | 48.5 | 84.2 | 83.8 | 76.2 | 84.2 | — | 22.2 | 100 |